Adam Shapiro

Dr. Adam Shapiro


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 May 2024 in Pediatrics
Verified
Journal Article
Closed access
PDF file
WWWallace B. Wee
Wallace B. Wee
BKBreAnna Kinghorn
BreAnna Kinghorn
SDStephanie D. Davis
Stephanie D. Davis
TFThomas W. Ferkol
Thomas W. Ferkol
ASAdam Shapiro
Adam Shapiro
Primary ciliary dyskinesia (PCD) is a rare, genetic disease characterized by dysfunctional motile cilia and abnormal mucociliary clearance, resulting in chronic sino-oto-pulmonary disease, neonatal respiratory distress, subfertility, and organ laterality defects. Over the past 2 decades, research and international collaborations have led to an improved understanding of disease prevalence, classic and variable phenotypes, novel diagnostics, genotype-phenotype correlations, long term morbidity, and innovative therapeutics. However, PCD is often underrecognized in clinical settings and the recent analyses of genetic databases suggest that only a fraction of these patients are being accurately diagnosed. Knowledge of significant advancements, from pathophysiology to the expanded range of clinical manifestations, will have important clinical impacts. These may include increasing disease recognition, improving diagnostic testing and management, and establishing an adequate pool of affected patients to enroll in upcoming clinical therapeutic trials. The objective of this state-of-the-art review is for readers to gain a greater understanding of the clinical spectrum of motile ciliopathies, cutting-edge diagnostic practices, emerging genotype-phenotype associations, and currently accepted management of people with PCD.

16 July 2021 in Diagnostics
Verified
Journal Article
Open access
PDF file
MOMichael O’Connor
Michael O’Connor
AHAmjad Horani
Amjad Horani
ASAdam Shapiro
Adam Shapiro
Primary Ciliary Dyskinesia (PCD) is a rare, under-recognized disease that affects respiratory ciliary function, resulting in chronic oto-sino-pulmonary disease. The PCD clinical phenotype overlaps with other common respiratory conditions and no single diagnostic test detects all forms of PCD. In 2018, PCD experts collaborated with the American Thoracic Society (ATS) to create a clinical diagnostic guideline for patients across North America, specifically considering the local resources and limitations for PCD diagnosis in the United States and Canada. Nasal nitric oxide (nNO) testing is recommended for first-line testing in patients ≥5 years old with a compatible clinical phenotype; however, all low nNO values require confirmation with genetic testing or ciliary electron micrograph (EM) analysis. Furthermore, these guidelines recognize that not all North American patients have access to nNO testing and isolated genetic testing is appropriate in cases with strong clinical PCD phenotypes. For unresolved diagnostic cases, referral to a PCD Foundation accredited center is recommended. The purpose of this narrative review is to provide insight on the North American PCD diagnostic process, to enhance the understanding of and adherence to current guidelines, and to promote collaboration with diagnostic pathways used outside of North America.

31 January 2025 in Fluids and Barriers of the CNS
Verified
Journal Article
Open access
PDF file
FEFranziska Eisenhuth
Franziska Eisenhuth
JAJoy E. Agbonze
Joy E. Agbonze
AGAdam M. R. Groh
Adam M. R. Groh
JKJesse M. Klostranec
Jesse M. Klostranec
DRDavid A. Rudko
David A. Rudko
ASAdam Shapiro
Adam Shapiro
Primary ciliary dyskinesia (PCD) is a genetic disorder causing motile ciliary dysfunction primarily affecting the respiratory and reproductive systems. However, the impact of PCD on the central nervous system remains poorly understood. Rodent models of PCD exhibit marked hydrocephalus leading to early animal mortality, however, most humans with PCD do not develop hydrocephalus for unknown reasons. We hypothesized that patients with PCD exhibit sub-clinical ventriculomegaly related to ependymal motile ciliary dysfunction. We demonstrated highly specific expression levels of known PCD-related genes in human brain multiciliated ependymal cells (p < 0.0001). To assess ventricular size, computed tomography sinus images from patients with PCD (n = 33) and age/sex-matched controls (n = 64) were analysed. Patients with PCD displayed significantly larger ventricular areas (p < 0.0001) and Evans index (p < 0.01), indicating ventriculomegaly that was consistent across all genetic subgroups. Ventricular enlargement correlated positively with increasing age in patients with PCD compared to controls (p < 0.001). Additionally, chart review demonstrated a high prevalence (39%) of neuropsychiatric/neurological disorders in adult PCD patients that did not correlate with degree of ventriculomegaly. Our findings suggest that patients with PCD may have unrecognized, mild ventriculomegaly which correlates with ageing, potentially attributable to ependymal ciliary dysfunction. Further study is required to determine causality, and whether ventricular enlargement contributes to neuropsychiatric/neurological or other morbidity in PCD.

11 May 2026 in Pediatric Pulmonology
Verified
Journal Article
Open access
MKMadhan Kumar
Madhan Kumar
DGDvir Gatt
Dvir Gatt
ZZZofia Zysman‐Colman
Zofia Zysman‐Colman
JFJosé Fontoura‐Matias
José Fontoura‐Matias
DFDeborah Fertuck
Deborah Fertuck
ASAdam Shapiro
Adam Shapiro
Background: Primary ciliary dyskinesia (PCD) is a genetically heterogeneous disorder causing chronic oto‐sino‐pulmonary disease from birth. Since diagnosis is often delayed into childhood or adulthood, early‐life disease burdens remain poorly described. Methods: This retrospective study analyzed disease burdens until 2 years of age and outcomes at 6‐7 years of age in children diagnosed with PCD near birth at two Canadian PCD centers. Results: Thirty‐five infants (median diagnostic age 34 days) were included. All received daily chest physiotherapy, while 52% received daily inhaled hypertonic saline therapy (IHS) from diagnosis. By 2 years of age, 66% experienced outpatient respiratory exacerbations, 29% had inpatient respiratory exacerbations, 60% required emergency room visits for respiratory illness, and 14% had Pseudomonas aeruginosa in sputum cultures. Abnormal audiology occurred in 91% screened, and 49% required tympanostomy tubes. Despite early diagnosis and therapy, spirometry showed a trend towards obstruction (mean FEV₁/FVC ratio Z‐score ‐1.43) by 7 years of age. Infants on daily IHS from birth (n = 18, mostly at one center) had significantly fewer Pseudomonas aeruginosa sputum isolates (0% vs. 29%, p = 0.02) but significantly increased inpatient respiratory exacerbations (44% vs. 12%, p = 0.04) compared to infants not on regular IHS ( n = 17). Conclusion: Despite early diagnosis, ongoing respiratory surveillance, and regular airway clearance, infants with PCD develop frequent respiratory infections and have high clinical care burdens. Infants have markedly increased risk of hearing loss, warranting universal screening and close follow‐up. Inhaled hypertonic saline may influence early Pseudomonas acquisition and hospitalization risk, warranting prospective study of this commonly prescribed therapy.

15 August 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
FEFranziska Eisenhuth
Franziska Eisenhuth
JAJoy E. Agbonze
Joy E. Agbonze
AGAdam M.R. Groh
Adam M.R. Groh
DRDavid A. Rudko
David A. Rudko
JSJo Anne Stratton
Jo Anne Stratton
ASAdam Shapiro
Adam Shapiro
Primary ciliary dyskinesia (PCD) is a genetic disorder causing motile ciliary dysfunction primarily affecting the respiratory and reproductive systems. However, the impact of PCD on the central nervous system, through dysfunction of motile cilia in multiciliated ependymal cells, remains poorly understood. We hypothesized that patients with PCD exhibit sub-clinical ventriculomegaly due to ependymal ciliary dysfunction, which may influence neuropsychiatric diagnoses. We demonstrated highly specific expression levels of known PCD-related genes in human brain ependymal cells ( p <0.0001), supporting their potential role in regulating ependymal ciliary function. Computed tomography sinus images from patients with PCD ( n =33) and age/sex-matched controls ( n =64) were analysed. Patients with PCD displayed significantly larger ventricular areas ( p <0.0001) and Evans index ( p <0.01), indicating ventriculomegaly that was consistent across all genetic subgroups. Ventricular enlargement correlated positively with increasing age in patients with PCD compared to controls ( p <0.001). Chart review demonstrated a high prevalence (39%) of neuropsychiatric/neurological disorders in adult PCD patients that did not correlate with degree of ventriculomegaly. Our findings suggest that patients with PCD may have unrecognized, mild ventriculomegaly potentially due to ependymal ciliary dysfunction which correlates with ageing. Further study is required to determine if ventricular enlargement contributes to neuropsychiatric/neurological or other morbidity in PCD.